| Year |
Citation |
Score |
| 2020 |
Goos JACM, Cho A, Carter LM, Dilling TR, Davydova M, Mandleywala K, Puttick S, Gupta A, Price WS, Quinn JF, Whittaker MR, Lewis JS, Davis TP. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect. Theranostics. 10: 567-584. PMID 31903138 DOI: 10.7150/Thno.36777 |
0.316 |
|
| 2019 |
Saunus J, Lim M, Puttick S, Croft PK, Houston Z, Jones M, Latter M, Campbell L, Thomas P, Jeffree R, Rose S, Mahler S, Thurecht K, Scott A, Lakhani S. Abstract P1-19-02: Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-19-02 |
0.302 |
|
| 2018 |
Clarke CJ, Puttick S, Sanderson TJ, Taylor AW, Bourne RA, Lovelock KRJ, Licence P. Thermal stability of dialkylimidazolium tetrafluoroborate and hexafluorophosphate ionic liquids: ex situ bulk heating to complement in situ mass spectrometry. Physical Chemistry Chemical Physics : Pccp. PMID 29888367 DOI: 10.1039/C8Cp01090K |
0.601 |
|
| 2018 |
Moonshi SS, Zhang C, Peng H, Puttick S, Rose S, Fisk NM, Bhakoo K, Stringer BW, Qiao GG, Gurr PA, Whittaker AK. A unique F MRI agent for the tracking of non phagocytic cells in vivo. Nanoscale. PMID 29682654 DOI: 10.1039/C8Nr00703A |
0.3 |
|
| 2017 |
Bell CM, Puttick S, Rose S, Smith J, Thomas P, Dowson N. Design and utilisation of protocols to characterise dynamic PET uptake of two tracers using basis pursuit. Physics in Medicine and Biology. PMID 28375137 DOI: 10.1088/1361-6560/Aa6B44 |
0.302 |
|
| 2017 |
Zhang C, Moonshi SS, Han Y, Puttick S, Peng H, Magoling BJA, Reid JC, Bernardi S, Searles DJ, Král P, Whittaker AK. PFPE-Based Polymeric 19F MRI Agents: A New Class of Contrast Agents with Outstanding Sensitivity Macromolecules. 50: 5953-5963. DOI: 10.1021/Acs.Macromol.7B01285 |
0.314 |
|
| 2016 |
Wang K, Peng H, Thurecht KJ, Puttick S, Whittaker AK. Multifunctional hyperbranched polymers for CT/19F MRI bimodal molecular imaging Polymer Chemistry. 7: 1059-1069. DOI: 10.1039/C5Py01707F |
0.327 |
|
| 2015 |
Puttick S, Stringer BW, Day BW, Bruce ZC, Ensbey KS, Mardon K, Cowin GJ, Thurecht KJ, Whittaker AK, Fay M, Boyd AW, Rose S. EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study. Molecular Imaging. 14: 385-99. PMID 26218510 DOI: 10.2310/7290.2015.00008 |
0.303 |
|
| 2015 |
Wang K, Peng H, Thurecht KJ, Puttick S, Whittaker AK. Segmented Highly-Branched Copolymers: Rationally Designed Macromolecules for Improved and Tuneable 19F MRI. Biomacromolecules. PMID 26218187 DOI: 10.1021/Acs.Biomac.5B00800 |
0.314 |
|
| 2014 |
Puttick S, Stringer BW, Day BW, Mardon K, Cowin GJ, Fay M, Thurecht KJ, Whittaker AK, Boyd AW, Rose S. Abstract LB-12: EphA2 as a diagnostic imaging target in glioblastoma: A PET/MRI study Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-12 |
0.314 |
|
| 2014 |
Wang K, Peng H, Thurecht KJ, Puttick S, Whittaker AK. Biodegradable core crosslinked star polymer nanoparticles as 19F MRI contrast agents for selective imaging Polymer Chemistry. 5: 1760-1771. DOI: 10.1039/C3Py01311A |
0.315 |
|
| 2013 |
Wang K, Peng H, Thurecht KJ, Puttick S, Whittaker AK. pH-responsive star polymer nanoparticles: potential 19F MRI contrast agents for tumour-selective imaging Polymer Chemistry. 4: 4480-4489. DOI: 10.1039/C3Py00654A |
0.306 |
|
| 2013 |
Puttick S, Davis AL, Butler K, Irvine DJ, Licence P, Thurecht KJ. The influence of domain segregation in ionic liquids upon controlled polymerisation mechanisms: RAFT polymerisation Polymer Chemistry. 4: 1337-1344. DOI: 10.1039/C2Py20835K |
0.594 |
|
| 2012 |
Taylor AW, Puttick S, Licence P. Probing solvation in ionic liquids via the electrochemistry of the DPPH radical. Journal of the American Chemical Society. 134: 15636-9. PMID 22978289 DOI: 10.1021/Ja3052816 |
0.652 |
|
| 2011 |
Puttick S, Davis AL, Butler K, Lambert L, El Harfi J, Irvine DJ, Whittaker AK, Thurecht KJ, Licence P. NMR as a probe of nanostructured domains in ionic liquids: Does domain segregation explain increased performance of free radical polymerisation? Chemical Science. 2: 1810-1816. DOI: 10.1039/C1Sc00207D |
0.59 |
|
| 2011 |
Boatwright AL, Puttick S, Licence P. Can a siphon work in vacuo? Journal of Chemical Education. 88: 1547-1550. DOI: 10.1021/Ed2001818 |
0.529 |
|
| 2009 |
Puttick S, Irvine DJ, Licence P, Thurecht KJ. RAFT-functional ionic liquids: Towards understanding controlled free radical polymerisation in ionic liquids Journal of Materials Chemistry. 19: 2679-2682. DOI: 10.1039/B817181P |
0.589 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Kryza T, Khan T, Puttick S, Li C, Sokolowski KA, Tse BW, Cuda T, Lyons N, Gough M, Yin J, Parkin A, Deryugina EI, Quigley JP, Law RHP, Whisstock JC, et al. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics. 10: 4116-4133. PMID 32226543 DOI: 10.7150/Thno.43589 |
0.299 |
|
| 2015 |
Puttick S, Boase NRB, Blakey I, Thurecht KJ. Imaging tumour distribution of a polymeric drug delivery platform in vivo by PET-MRI Journal of Chemical Technology & Biotechnology. 90: 1237-1244. DOI: 10.1002/Jctb.4489 |
0.298 |
|
| 2014 |
Bell C, Rose S, Puttick S, Pagnozzi A, Poole CM, Gal Y, Thomas P, Fay M, Jeffree RL, Dowson N. Dual acquisition of (18)F-FMISO and (18)F-FDOPA. Physics in Medicine and Biology. 59: 3925-49. PMID 24958083 DOI: 10.1088/0031-9155/59/14/3925 |
0.296 |
|
| 2016 |
Zhang C, Peng H, Li W, Liu L, Puttick S, Reid J, Bernardi S, Searles DJ, Zhang A, Whittaker AK. Conformation Transitions of Thermoresponsive Dendronized Polymers across the Lower Critical Solution Temperature Macromolecules. 49: 900-908. DOI: 10.1021/Acs.Macromol.5B02414 |
0.295 |
|
| 2015 |
Bell C, Dowson N, Fay M, Thomas P, Puttick S, Gal Y, Rose S. Hypoxia imaging in gliomas with 18F-fluoromisonidazole PET: toward clinical translation. Seminars in Nuclear Medicine. 45: 136-50. PMID 25704386 DOI: 10.1053/J.Semnuclmed.2014.10.001 |
0.294 |
|
| 2016 |
Zhang C, Moonshi SS, Peng H, Puttick S, Reid J, Bernardi S, Searles DJ, Whittaker AK. Ion-responsive 19F MRI contrast agents for the detection of cancer cells Acs Sensors. 1: 757-765. DOI: 10.1021/Acssensors.6B00216 |
0.293 |
|
| 2015 |
Zhang C, Peng H, Puttick S, Reid J, Bernardi S, Searles DJ, Whittaker AK. Conformation of hydrophobically modified thermoresponsive poly(OEGMA-co-TFEA) across the LCST revealed by NMR and molecular dynamics studies Macromolecules. 48: 3310-3317. DOI: 10.1021/Acs.Macromol.5B00641 |
0.29 |
|
| 2015 |
Bell C, Dowson N, Puttick S, Gal Y, Thomas P, Fay M, Smith J, Rose S. Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma. Nuclear Medicine and Biology. PMID 26162582 DOI: 10.1016/J.Nucmedbio.2015.06.001 |
0.289 |
|
| 2015 |
Puttick S, Bell C, Dowson N, Rose S, Fay M. PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma. Drug Discovery Today. 20: 306-17. PMID 25448762 DOI: 10.1016/J.Drudis.2014.10.016 |
0.287 |
|
| 2016 |
Dowson N, Baker C, Thomas P, Smith J, Puttick S, Bell C, Salvado O, Rose S. Federated optimisation of kinetic analysis problems. Medical Image Analysis. 35: 116-132. PMID 27352142 DOI: 10.1016/J.Media.2016.06.019 |
0.276 |
|
| 2018 |
Offenhäuser C, Al-Ejeh F, Puttick S, Ensbey KS, Bruce ZC, Jamieson PR, Smith FM, Stringer BW, Carrington B, Fuchs AV, Bell CA, Jeffree R, Rose S, Thurecht KJ, Boyd AW, et al. EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma. Cancers. 10. PMID 30562956 DOI: 10.3390/Cancers10120519 |
0.275 |
|
| 2019 |
Lim M, Puttick S, Houston ZH, Thurecht KJ, Kalita-de Croft P, Mahler S, Rose SE, Jeffree RL, Mazzieri R, Dolcetti R, Lakhani SR, Saunus JM. Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases. International Journal of Molecular Sciences. 20. PMID 30875730 DOI: 10.3390/Ijms20061280 |
0.27 |
|
| 2020 |
Houston ZH, Bunt J, Chen KS, Puttick S, Howard CB, Fletcher NL, Fuchs AV, Cui J, Ju Y, Cowin G, Song X, Boyd AW, Mahler SM, Richards LJ, Caruso F, et al. Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies. Acs Central Science. 6: 727-738. PMID 32490189 DOI: 10.1021/Acscentsci.9B01299 |
0.264 |
|
| 2020 |
Cuda TJ, Riddell AD, Liu C, Whitehall VL, Borowsky J, Wyld DK, Burge ME, Ahern E, Griffin A, Lyons NJ, Rose SE, Clark DA, Stevenson AR, Hooper JD, Puttick S, et al. PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32358088 DOI: 10.2967/Jnumed.119.233312 |
0.264 |
|
| 2017 |
Sinha S, Tong WY, Williamson NH, McInnes SJP, Puttick S, Cifuentes-Rius A, Bhardwaj R, Plush SE, Voelcker NH. Novel Gd-Loaded Silicon Nanohybrid: A Potential EGFR Expressing Cancer Cell Targeting MRI Contrast Agent. Acs Applied Materials & Interfaces. PMID 29154535 DOI: 10.1021/Acsami.7B14538 |
0.264 |
|
| 2020 |
Goos JACM, Davydova M, Dilling TR, Cho A, Cornejo MA, Gupta A, Price WS, Puttick S, Whittaker MR, Quinn JF, Davis TP, Lewis JS. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue. Nuclear Medicine and Biology. 84: 63-72. PMID 32135473 DOI: 10.1016/J.Nucmedbio.2020.02.012 |
0.262 |
|
| 2019 |
White AL, Langton C, Wille ML, Hitchcock J, Cayre OJ, Biggs S, Blakey I, Whittaker AK, Rose S, Puttick S. Ultrasound-triggered release from metal shell microcapsules. Journal of Colloid and Interface Science. 554: 444-452. PMID 31325678 DOI: 10.1016/J.Jcis.2019.07.020 |
0.26 |
|
| 2020 |
Li J, Wuethrich A, Dey S, Lane RE, Sina AAI, Wang J, Wang Y, Puttick S, Koo KM, Trau M. The growing impact of micro/nanomaterial‐based systems in precision oncology: translating “multiomics” technologies Advanced Functional Materials. 1909306. DOI: 10.1002/Adfm.201909306 |
0.26 |
|
| 2020 |
Brighi C, Reid L, Genovesi LA, Kojic M, Millar A, Bruce Z, White AL, Day BW, Rose S, Whittaker AK, Puttick S. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity. Theranostics. 10: 6361-6371. PMID 32483457 DOI: 10.7150/Thno.46468 |
0.258 |
|
| 2017 |
Ku K, Grøndahl L, Dao H, Du K, Puttick S, Lai P, Peng H, Chu I, Whittaker AK. In vitro degradation study of polyanhydride copolymers / surface grafted hydroxyapatite composites for bone tissue application Polymer Degradation and Stability. 140: 136-146. DOI: 10.1016/J.Polymdegradstab.2017.04.021 |
0.256 |
|
| 2018 |
Tasker AL, Puttick S, Hitchcock J, Cayre OJ, Blakey I, Whittaker AK, Biggs S. A two-step synthesis for preparing metal microcapsules with a biodegradable polymer substrate. Journal of Materials Chemistry. B. 6: 2151-2158. PMID 32254438 DOI: 10.1039/C8Tb00348C |
0.252 |
|
| 2020 |
Harrington BS, He Y, Khan T, Puttick S, Conroy PJ, Kryza T, Cuda T, Sokolowski KA, Tse BW, Robbins KK, Arachchige BJ, Stehbens SJ, Pollock PM, Reed S, Weroha SJ, et al. Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer. Theranostics. 10: 2095-2114. PMID 32104500 DOI: 10.7150/Thno.30736 |
0.252 |
|
| 2018 |
Tasker A, Sainsbury F, Puttick S. Particle-Stabilized Fluid-Fluid Interfaces: The Impact of Core Composition on Interfacial Structure. Frontiers in Chemistry. 6: 383. PMID 30214900 DOI: 10.3389/Fchem.2018.00383 |
0.247 |
|
| 2018 |
Brighi C, Puttick S, Rose S, Whittaker AK. The potential for Remodelling the Tumour Vasculature in Glioblastoma. Advanced Drug Delivery Reviews. PMID 30308226 DOI: 10.1016/J.Addr.2018.10.001 |
0.242 |
|
| 2019 |
Lee MD, Tong WY, Nebl T, Pearce LA, Pham TM, Golbaz-Hagh A, Puttick S, Rose S, Adams TE, Williams CC. Dual Site-Specific Labelling of an Antibody Fragment Through Sortase A and π-clamp Conjugation. Bioconjugate Chemistry. PMID 31560523 DOI: 10.1021/Acs.Bioconjchem.9B00639 |
0.241 |
|
| 2018 |
Offenhauser C, Carrington B, Thurecht K, Ensbey K, Bruce Z, Jamieson P, Lim YC, Akgul S, Li M, Stringer B, Puttick S, Fuchs A, Picard D, Ingram W, Hallahan A, et al. MBRS-09. EphA3 A NOVEL TUMOUR SPECIFIC THERAPEUTIC TARGET FOR MEDULLOBLASTOMA. Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.454 |
0.24 |
|
| 2016 |
Puttick S, Dowson N, Fay M, Bell C, Martin J, Rose S. Effect of Ligand Size On Uptake Andwashout of Epha2 Targeted Theranostics From Glioblastomas Using 64Cu-Pet Journal of Cerebral Blood Flow and Metabolism. 36: 613-614. DOI: 10.1177/0271678X16639008 |
0.239 |
|
| 2020 |
Li J, Wuethrich A, Dey S, Lane RE, Sina AAI, Wang J, Wang Y, Puttick S, Koo KM, Trau M. Multiomics: The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies (Adv. Funct. Mater. 37/2020) Advanced Functional Materials. 30. DOI: 10.1002/Adfm.202070248 |
0.212 |
|
| 2021 |
White AL, Javier HA, Withey S, Biggs SR, Rose S, Puttick SG, Whittaker AK. Deposition of non-porous calcium phosphate shells onto liquid filled microcapsules. Journal of Colloid and Interface Science. PMID 34848058 DOI: 10.1016/j.jcis.2021.11.062 |
0.205 |
|
| 2021 |
Cuda TJ, He Y, Kryza T, Khan T, Tse BW, Sokolowski KA, Liu C, Lyons N, Gough M, Snell CE, Wyld DK, Rose S, Riddell AD, Stevenson ARL, Thomas PA, ... ... Puttick S, et al. Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer. Contrast Media & Molecular Imaging. 2021: 3153278. PMID 34621145 DOI: 10.1155/2021/3153278 |
0.164 |
|
| 2022 |
Brighi C, Puttick S, Li S, Keall P, Neville K, Waddington D, Bourgeat P, Gillman A, Fay M. A novel semiautomated method for background activity and biological tumour volume definition to improve standardisation of F-FET PET imaging in glioblastoma. Ejnmmi Physics. 9: 9. PMID 35122529 DOI: 10.1186/s40658-022-00438-2 |
0.155 |
|
| 2022 |
Khan T, Lyons NJ, Gough M, Kwah KKX, Cuda TJ, Snell CE, Tse BW, Sokolowski KA, Pearce LA, Adams TE, Rose SE, Puttick S, Pajic M, Adams MN, He Y, et al. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy. Theranostics. 12: 6915-6930. PMID 36276654 DOI: 10.7150/thno.78171 |
0.134 |
|
| 2023 |
Li J, Howard CB, Dey S, Lowry K, Whiley DM, Puttick S, Rose S, Lobb RJ, Wuethrich A, Edwardraja S, Trau M. A universal reagent for detection of emerging diseases using bioengineered multifunctional yeast nanofragments. Nature Nanotechnology. PMID 37291255 DOI: 10.1038/s41565-023-01415-1 |
0.13 |
|
| 2022 |
Brighi C, Salimova E, de Veer M, Puttick S, Egan G. Translation of focused ultrasound for blood-brain barrier opening in glioma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 35337938 DOI: 10.1016/j.jconrel.2022.03.035 |
0.126 |
|
| 2020 |
Brighi C, Reid L, White AL, Genovesi LA, Kojic M, Millar A, Bruce Z, Day BW, Rose S, Whittaker AK, Puttick S. MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma. Neuro-Oncology Advances. 2: vdaa030. PMID 32642689 DOI: 10.1093/noajnl/vdaa030 |
0.123 |
|
| 2023 |
Brighi C, Puttick S, Woods A, Keall P, Tooney PA, Waddington DEJ, Sproule V, Rose S, Fay M. Comparison between [Ga]Ga-PSMA-617 and [F]FET PET as Imaging Biomarkers in Adult Recurrent Glioblastoma. International Journal of Molecular Sciences. 24. PMID 38003399 DOI: 10.3390/ijms242216208 |
0.116 |
|
| 2021 |
Li J, Wuethrich A, Edwardraja S, Lobb RJ, Puttick S, Rose S, Howard CB, Trau M. Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay. Analytical Chemistry. PMID 34264067 DOI: 10.1021/acs.analchem.1c01657 |
0.111 |
|
| 2021 |
He Y, Khan T, Kryza T, Jones ML, Goh JB, Lyons NJ, Pearce LA, Lee MD, Gough M, Rogers R, Davies CM, Gilks CB, Hodgkinson T, Lourie R, Barry SC, ... ... Puttick S, et al. Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer. Molecular Pharmaceutics. PMID 34448393 DOI: 10.1021/acs.molpharmaceut.1c00401 |
0.103 |
|
| 2021 |
Genovesi LA, Puttick S, Millar A, Kojic M, Ji P, Lagendijk AK, Brighi C, Bonder CS, Adolphe C, Wainwright BJ. Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier. Neuro-Oncology. 23: 732-742. PMID 33258962 DOI: 10.1093/neuonc/noaa266 |
0.096 |
|
| 2024 |
Griffiths MR, Pattison DA, Latter M, Kuan K, Taylor S, Tieu W, Kryza T, Meyrick D, Lee BQ, Hansen A, Rose SE, Puttick SG. First-in-Human Pb-PSMA-Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38423783 DOI: 10.2967/jnumed.123.267189 |
0.092 |
|
| 2022 |
Brighi C, Salimova E, de Veer M, Puttick S, Egan G. Reply to Letter from Price et al, re: Translation of focused ultrasound for blood-brain barrier opening in glioma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 35780953 DOI: 10.1016/j.jconrel.2022.06.042 |
0.032 |
|
| 2014 |
Buonincontri G, Wood NI, Puttick SG, Ward AO, Carpenter TA, Sawiak SJ, Morton AJ. Right ventricular dysfunction in the R6/2 transgenic mouse model of Huntington's disease is unmasked by dobutamine. Journal of Huntington's Disease. 3: 25-32. PMID 24744818 DOI: 10.3233/JHD-130083 |
0.02 |
|
| Hide low-probability matches. |